<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04834687</url>
  </required_header>
  <id_info>
    <org_study_id>ZDGW[2021]044</org_study_id>
    <nct_id>NCT04834687</nct_id>
  </id_info>
  <brief_title>Effects of Diet and Exercise Interventions on Cardiometabolic Risk Markers, Executive Function, and Intestinal Flora</brief_title>
  <official_title>Effects of Diet and Exercise Interventions on Cardiometabolic Risk Markers, Executive Function, and Intestinal Flora in Undergraduate Students: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to estimate the effects of diet and exercise interventions on&#xD;
      body weight, cardiovascular metabolic markers, executive function, and intestinal flora among&#xD;
      undergraduate students, as well as the underlying mechanisms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In recent decades, unhealthy dietary patterns and insufficiency of physical activity have&#xD;
      brought negative effects on human health, such as rapid increasing incidence of obesity,&#xD;
      metabolic cardiovascular diseases, and mental disorders. The first line of prevention and&#xD;
      therapy for these diseases is proper diet and lifestyle interventions. A series of studies&#xD;
      conducted in vivo and vitro have shown that high-fiber diets and time-restricted eating&#xD;
      present benefits in weight loss, reducing cardiovascular disease risk, and improving&#xD;
      cognitive function. While, there is also a randomized controlled trial do not observe the&#xD;
      effects of time-restricted eating on weight loss and decrease of metabolic risks. Meanwhile,&#xD;
      few studies have examined the effects of high-fiber diets or time-restricted eating on&#xD;
      executive function. Additionally, previous studies on high-fiber diets and time-restricted&#xD;
      eating focused on middle-aged or elderly populations with some features of metabolic&#xD;
      syndrome, while the effects on healthy young populations are unclear. More importantly, there&#xD;
      are a small amount of studies exploring the combined effects of time-restricted eating and&#xD;
      physical activity on metabolism and cognitive function. Therefore, our study is to estimate&#xD;
      the effects of diet (high-fiber diets and time-restricted eating) and exercise&#xD;
      (rope-skipping) interventions on body weight, cardiovascular metabolic markers, executive&#xD;
      function, and intestinal flora among undergraduate students, as well as the underlying&#xD;
      mechanisms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>Body weight change of participants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>Body fat percentage were measured by body composition analyzers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat mass</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>Fat mass (in kg) were measured by body composition analyzers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic and diastolic blood pressure</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>Sitting systolic and diastolic blood pressure were measured with a validated electronic blood pressure monitor (model OMRON,HEM-7124).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum lipid levels</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>Serum lipid levels (total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides) were analyzed by the enzymatic method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma glucose</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>Fasting plasma glucose were analyzed by the glucose oxidase method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma insulin</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>Fasting plasma glucose were analyzed by the electrochemiluminescence method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal flora</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>To measure the change of intestinal flora by analyzing feces genome 16S rDNA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in scores on Behaviour Rating Inventory of Executive Functioning-Adult Version (BRIEF-A)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The executive functions were measured by the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Self-Report Form. Items are rated 1 (never), 2 (sometimes), and 3 (often). There is no range for a total score. Raw scale scores are used to generate T-scores. A reduction in score indicates less impairment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in appetite sensations</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The appetite sensations were measured by the visual analogue scale (VAS).The VAS consisted of 100-mm lines and participants were required to place a vertical mark across the line corresponding best to their feelings of hunger, satisfaction, and fullness, with the scale ranging from 0 (not at all) to 100 (extremely). Quantification was performed by measuring the distance between the left end of the line and the vertical mark.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-Sensitivity C-Reactive Protein (hs-CRP)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum hs-CRP were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intercellular adhesion molecule-1 (ICAM-1)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum ICAM-1 were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor necrosis factor alpha (TNF-alpha)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum TNF-alpha were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chemokine CCL2</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum chemokine CCL2 were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular cell adhesion molecule (VCAM-1)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum VCAM-1 were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-6 (IL-6)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum IL-6 were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-8 (IL-8)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the IL-8 were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leptin</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum leptin were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tau protein</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum tau protein were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain-derived neurotrophic factor (BDNF)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum BDNF were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular endothelial growth factor (VEGF)</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>The levels of the serum VEGF were analyzed using the Luminex Human Magnetic Assay kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circulating metabolome</measure>
    <time_frame>Baseline (1-2 days before the intervention), right after intervention (12 weeks)</time_frame>
    <description>To measure the change of circulating metabolome by LC-MS/MS method.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cardiometabolic Risk</condition>
  <condition>Executive Function</condition>
  <condition>Intestinal Microbiome</condition>
  <arm_group>
    <arm_group_label>Rope-skipping group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants would be required to take part in an exercise plan, under the instruction and guidance of professional sports teachers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants would be required to take part in a diet plan , including a high-fiber diet and time-restricted eating.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive both rope-skipping and diet interventions at the same time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants would be required to maintain existing diet patterns and physical activity levels.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Rope-skipping exercise for three times a week (90 minutes each time, and there is a 10 min break after 20 min Rope skipping). Exercise bracelet and smart bracelet would be used to record the energy consumption throughout the study.</description>
    <arm_group_label>Combined intervention group</arm_group_label>
    <arm_group_label>Rope-skipping group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>Diet interventions include ten-hour time-restricted eating and a high-fiber diet.&#xD;
Participants will be instructed to take food from 7:30 AM until 5:30 PM and completely abstain from caloric intake for the remainder of the day (14 hours fast:10 hours eat). Only noncaloric beverages were permitted outside of the eating widow.&#xD;
According to the dietary recommendation proposed by Chinese Government and the existing dishes in the canteen , participants are instructed to eat following a high-diet recipe weekly from Monday to Friday which includes whole grain wheat rice, vegetables, fruits, and other foods rich in dietary fiber .</description>
    <arm_group_label>Combined intervention group</arm_group_label>
    <arm_group_label>Diet intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First and second year undergraduate students in Sun Yat-sen University.&#xD;
&#xD;
          -  BMIâ‰¥22 kg/m^2.&#xD;
&#xD;
          -  Keeping weight stable for 3 months prior to study start (weight fluctuation &lt;5kg).&#xD;
&#xD;
          -  Having the time and volunteering to receive the interventions.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently engaged in other weight-loss studies.&#xD;
&#xD;
          -  With high blood pressure, diabetes or other cardiovascular diseases.&#xD;
&#xD;
          -  With secondary obesity induced by medicine or other diseases.&#xD;
&#xD;
          -  Contraindication to exercise.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yanna Zhu, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yanna Zhu, M.D</last_name>
    <phone>86-20-87330663</phone>
    <email>zhuyn3@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ying Ding, M.M</last_name>
    <phone>86-20-87335573</phone>
    <email>dingy69@mail.sysu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Maternal and Child Health and Sun Yat-sen Global Health Institute, School of Public Health and Institute of State Governance, Sun Yatsen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanna Zhu, M.D</last_name>
      <phone>86-20-87330663</phone>
      <email>zhuyn3@mail.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 3, 2021</study_first_submitted>
  <study_first_submitted_qc>April 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Yanna Zhu</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Dietary Fiber</keyword>
  <keyword>Time Restricted Feeding</keyword>
  <keyword>Exercise</keyword>
  <keyword>Young Adult</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

